These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34644768)

  • 1. Dexamethasone for treating SARS-CoV-2 infection: a systematic review and meta-analysis.
    Ferreto LED; Bortoloti DS; Fortes PCN; Follador F; Arruda G; Ximenez JP; Wendt GW
    Sao Paulo Med J; 2021; 139(6):657-661. PubMed ID: 34644768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study.
    Mühlemann B; Thibeault C; Hillus D; Helbig ET; Lippert LJ; Tober-Lau P; Schwarz T; Müller MA; ; Witzenrath M; Suttorp N; Sander LE; Drosten C; Jones TC; Corman VM; Kurth F
    Clin Microbiol Infect; 2021 Oct; 27(10):1520.e7-1520.e10. PubMed ID: 34139335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis.
    Baldini T; Asioli GM; Romoli M; Carvalho Dias M; Schulte EC; Hauer L; Aguiar De Sousa D; Sellner J; Zini A
    Eur J Neurol; 2021 Oct; 28(10):3478-3490. PubMed ID: 33426733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.
    Talic S; Shah S; Wild H; Gasevic D; Maharaj A; Ademi Z; Li X; Xu W; Mesa-Eguiagaray I; Rostron J; Theodoratou E; Zhang X; Motee A; Liew D; Ilic D
    BMJ; 2021 Nov; 375():e068302. PubMed ID: 34789505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.
    Pinzón MA; Ortiz S; Holguín H; Betancur JF; Cardona Arango D; Laniado H; Arias Arias C; Muñoz B; Quiceno J; Jaramillo D; Ramirez Z
    PLoS One; 2021; 16(5):e0252057. PubMed ID: 34033648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Dexamethasone Treatment After Hospital Discharge for Patients With COVID-19 Infection and Rates of Hospital Readmission and Mortality.
    Huang CW; Yu AS; Song H; Park JS; Wu SS; Khang VK; Subject CC; Shen E
    JAMA Netw Open; 2022 Mar; 5(3):e221455. PubMed ID: 35258575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
    JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic corticosteroids for the treatment of COVID-19.
    Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Efficacy and Safety of Low-Dose Versus High-Dose Dexamethasone in Hospitalized COVID-19 Patients: A Meta-Analysis.
    Waheed MD; Shaikh A; Sidhu SM; Ahmad S; Sikander T; Chaudhry AR; Iftikhar I; Shaik TA
    Cureus; 2023 Jan; 15(1):e33884. PubMed ID: 36819444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study.
    Benfield T; Bodilsen J; Brieghel C; Harboe ZB; Helleberg M; Holm C; Israelsen SB; Jensen J; Jensen TØ; Johansen IS; Johnsen S; Lindegaard B; Lundgren J; Meyer CN; Mohey R; Pedersen LM; Nielsen H; Nielsen SL; Obel N; Omland LH; Podlekareva D; Poulsen BK; Ravn P; Sandholdt H; Starling J; Storgaard M; Søborg C; Søgaard OS; Tranborg T; Wiese L; Christensen HR
    Clin Infect Dis; 2021 Dec; 73(11):2031-2036. PubMed ID: 34111274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study.
    Stanevich OV; Fomina DS; Bakulin IG; Galeev SI; Bakin EA; Belash VA; Kulikov AN; Lebedeva AA; Lioznov DA; Polushin YS; Shlyk IV; Vorobyev EA; Vorobyeva SV; Surovceva TV; Bakulina NV; Lysenko MA; Moiseev IS
    BMC Infect Dis; 2021 Dec; 21(1):1277. PubMed ID: 34937556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Outcomes Associated With SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis.
    Sumner MW; Kanngiesser A; Lotfali-Khani K; Lodha N; Lorenzetti D; Funk AL; Freedman SB
    Front Pediatr; 2022; 10():916655. PubMed ID: 35757137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis.
    He S; Hecimovic A; Matijasevic V; Mai HT; Heslop L; Foster J; Alexander KE; Pal N; Alexandrou E; Davidson PM; Frost SA
    J Clin Nurs; 2022 Jun; 31(11-12):1557-1569. PubMed ID: 34570947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis.
    Kim J; Miyazaki K; Shah P; Kozai L; Kewcharoen J
    Healthcare (Basel); 2022 Mar; 10(4):. PubMed ID: 35455823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.
    Li H; Chen C; Hu F; Wang J; Zhao Q; Gale RP; Liang Y
    Leukemia; 2020 Jun; 34(6):1503-1511. PubMed ID: 32372026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.